ClinicalTrials.Veeva
Menu

Find clinical trials for Alzheimer's Disease in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Alzheimer Disease
Dementia
Cognitive Dysfunction
Mental Disorders
Brain Diseases
Neurodegenerative Diseases
Nervous System Diseases

Alzheimer's Disease trials near Austin, TX, USA:

A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease

and efficacy of ONO-2020 in participants with mild to moderate Alzheimer's disease (AD). This study aims to determine whether admin ...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: ONO-2020

Phase 2

Ono Pharmaceuticals
Ono Pharmaceuticals

Austin, Texas, United States and 95 other locations

administered once every four weeks (Q4W) in slowing cognitive and functional decline as compared to placebo in participants with early Alzheimer's...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: sabirnetug

Phase 2

Acumen Pharmaceuticals

Austin, Texas, United States of America and 73 other locations

Locations recently updated

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease...

Enrolling
Alzheimer's Disease
Other: Placebo
Drug: KarXT

Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Round Rock, Texas, United States and 124 other locations

Xanamem® is being developed as a potential treatment for symptomatic, early stages of Alzheimer's Disease (AD) and Major Depressive...

Active, not recruiting
Alzheimer Disease
Dementia, Mild
Drug: Placebo
Drug: Xanamem

Phase 2, Phase 3

Actinogen Medical

Austin, Texas, United States and 34 other locations

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determin...

Active, not recruiting
Early Alzheimer's Disease
Drug: Lecanemab SC
Drug: Placebo

Phase 3

Eisai
Eisai

Austin, Texas, United States of America and 246 other locations

The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease...

Enrolling
Alzheimer Disease
Drug: Placebo
Drug: KarXT

Phase 3

Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Austin, Texas, United States and 294 other locations

study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants with Early Alzheimer's...

Active, not recruiting
Alzheimer Disease, Early Onset
Other: Placebo
Drug: BMS-986446

Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Austin, Texas, United States and 201 other locations

to evaluate the efficacy, safety, and tolerability of BMS-986368, a FAAH/MAGL inhibitor, for the treatment of agitation in participants with Alzheimer's...

Enrolling
Alzheimer Disease
Agitation
Drug: Placebo
Drug: BMS-986368

Phase 2

Celgene
Celgene

Austin, Texas, United States and 54 other locations

The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's...

Active, not recruiting
Alzheimer's Disease
Drug: Placebo
Drug: Remternetug

Phase 3

Lilly
Lilly

Austin, Texas, United States of America and 265 other locations

The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

Phase 3

Lilly
Lilly

Austin, Texas, United States and 223 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems